Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

ABSTRACT: For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in areas of the African Sahel and sub-Sahel known as the African meningitis belt. Until recently, the main approach to the control of these epidemics has been reactive vaccination with a polysaccharide vaccine after an outbreak has reached a defined threshold and provision of easy access to effective treatment but this approach has not prevented the occurrence of new epidemics. Meningococcal conjugate vaccines, which can prevent meningococcal carriage and thus interrupt transmission, may be more effective than polysaccharide vaccines at preventing epidemics. Because the majority of African epidemics have been caused by serogroup A meningococci, a serogroup A polysaccharide/tetanus toxoid protein c

SUBMITTER: Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa 

PROVIDER: S-EPMC3988351 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature